MIF and neoplasm: These findings collectively suggest that in HER2+ IBC, tumour-derived MIF activates CD74 on CD8+ T cells, triggering p38 MAPK signalling and NFAT1 nuclear translocation, which drives transcriptional activation of LAG3 and TIGIT.